Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tarik Exner

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids|March 13, 2018
The metabolic capacity of lipid droplet localized acyl-CoA synthetase 3 is not sufficient to support local triglyceride synthesis independent of the endoplasmic reticulum in A431 cellsMargarete Poppelreuther, Simone Sander, Fadil Minden, et al.
Annals of the Rheumatic Diseases|February 16, 2022
Ageing and interferon gamma response drive the phenotype of neutrophils in the inflamed jointRicardo Grieshaber-Bouyer, Tarik Exner, Nicolaj S Hackert, et al.
Annals of the Rheumatic Diseases|June 19, 2026
Teclistamab for treatment-refractory autoimmune diseases: a multicentre case seriesFredrik N Albach, Elpida Phithak, Robert Biesen, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids|March 13, 2018
The metabolic capacity of lipid droplet localized acyl-CoA synthetase 3 is not sufficient to support local triglyceride synthesis independent of the endoplasmic reticulum in A431 cellsMargarete Poppelreuther, Simone Sander, Fadil Minden, et al.
Annals of the Rheumatic Diseases|February 16, 2022
Ageing and interferon gamma response drive the phenotype of neutrophils in the inflamed jointRicardo Grieshaber-Bouyer, Tarik Exner, Nicolaj S Hackert, et al.
Annals of the Rheumatic Diseases|June 19, 2026
Teclistamab for treatment-refractory autoimmune diseases: a multicentre case seriesFredrik N Albach, Elpida Phithak, Robert Biesen, et al.
Pageof 2